Xylocaine, Lidocaine HCl

Avenacy 10 N. Martingale Road

Revision date : 2025-08-04

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS07
Health risk rating 3
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

99-76-3

Name of the chemical

4-hydroxybenzoic acid, methyl ester

Concentration

N/A

EC/CAS

1310-73-2

Name of the chemical

sodium hydroxide

Concentration

N/A

EC/CAS

7647-01-0

Name of the chemical

Hydrochloric acid

Concentration

N/A

EC/CAS

7732-18-5

Name of the chemical

Water, distilled, conductivity or of similar purity H2O

Concentration

N/A

General Information

Version

Page

Revision date

2025-08-04

Product name

Xylocaine, Lidocaine HCl

Chemical name

acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl)-, monohydrochloride monohydrate

1.2.1 Relevant identified uses

Pharmaceutical, Injectable

Icons in SDS

M004 M009 M010 M011 GHS07

Company Information

company name

Avenacy 10 N. Martingale Road

GHS Information

Signal word

(c) Description of Hazards

Hazard Codes

Hazard statements (CLP)

H302

Hazard statements

Code

Statements

H302

Harmful if swallowed

Section 2

SECTION 2: Hazards identification

Not classified as hazardous

Signal word

c) Description of Hazards: and/or Precautionary None

Hazard statements

Not classified in accordance with international standards for workplace safety.

Precautionary statements

Harmful if swallowed. May cause mild eye irritation. May cause slight skin irritation. (based on components). Drugs of this class have been associated with rare, but potentially serious cardiac events. These events have not been observed from occupational exposures, however, those with preexisting cardiovascular illnesses may be at increased risk from exposure. Known Clinical Effects Adverse effects associated with the therapeutic use include dizziness, nervousness, agitation, drowsiness, apprehension, euphoria, blurred/double vision, slurred speech, tremors, convulsions, and seizure. Respiratory depression and arrest may follow. Other, more serious effects seen with IV use of this drug, particularly when it is administered rapidly, are cardiovascular collapse, central nervous system depression, and/or hypotension. (d) Unknown Acute Toxicity N/A

2.1 Classification of the substance or mixture

Not classified as hazardous. (b) Signal Word, Hazard (c) Description of Hazards

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.